BioCentury | Dec 21, 2015
Company News

Oncotest, Charles River deal

...Charles River acquired CRO Oncotest for EUR34 million ($36.1 million) in cash. Oncotest is eligible for...
...payment. Charles River declined to provide further details, and Oncotest did not respond to inquiries. Oncotest GmbH...
BioCentury | May 13, 2013
Company News

Debiopharm, Oncotest deal

...Debiopharm and Oncotest announced that they had identified several predictive biomarker candidates, including a gene signature...
...undisclosed compound from Debiopharm and Oncotest's 3D assay system for patient-derived tumor xenografts correlated with Oncotest's...
...genomic and transcriptomics data. The companies declined to disclose details. Debiopharm Group , Lausanne, Switzerland Oncotest GmbH...
BioCentury | Jan 17, 2011
Company News

Caris Life Sciences sales and marketing update

...is provided in Israel via Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA, Petah Tikva, Israel) group member Oncotest...
BioCentury | Apr 16, 2009
Distillery Therapeutics

Indication: Cancer

...Chem.; published online March 20, 2009; doi:10.1021/jm800988r Contact: Thomas Beckers, Nycomed GmbH, Konstanz, Germany e-mail: Thomas.Beckers@oncotest.de...
Items per page:
1 - 4 of 4
BioCentury | Dec 21, 2015
Company News

Oncotest, Charles River deal

...Charles River acquired CRO Oncotest for EUR34 million ($36.1 million) in cash. Oncotest is eligible for...
...payment. Charles River declined to provide further details, and Oncotest did not respond to inquiries. Oncotest GmbH...
BioCentury | May 13, 2013
Company News

Debiopharm, Oncotest deal

...Debiopharm and Oncotest announced that they had identified several predictive biomarker candidates, including a gene signature...
...undisclosed compound from Debiopharm and Oncotest's 3D assay system for patient-derived tumor xenografts correlated with Oncotest's...
...genomic and transcriptomics data. The companies declined to disclose details. Debiopharm Group , Lausanne, Switzerland Oncotest GmbH...
BioCentury | Jan 17, 2011
Company News

Caris Life Sciences sales and marketing update

...is provided in Israel via Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA, Petah Tikva, Israel) group member Oncotest...
BioCentury | Apr 16, 2009
Distillery Therapeutics

Indication: Cancer

...Chem.; published online March 20, 2009; doi:10.1021/jm800988r Contact: Thomas Beckers, Nycomed GmbH, Konstanz, Germany e-mail: Thomas.Beckers@oncotest.de...
Items per page:
1 - 4 of 4